Skip to content
10-K

Annual Report

Guardant Health, Inc. GH

0001576280-25-000044

← back to feed
Filed
Feb 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 14, 2025 123.42M sh
Current Liabilities FY 2024 · Dec 31, 2023 $205.92M
Total Liabilities FY 2024 · Dec 31, 2023 $1.63B
Current Assets FY 2024 · Dec 31, 2023 $1.35B
Total Assets FY 2024 · Dec 31, 2023 $1.79B
Shares Diluted FY 2024 · Dec 31, 2022 102.18M sh
Capex FY 2024 · Dec 31, 2022 $77.46M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$309.46M
Cash And Equivalents FY 2024 · Dec 31, 2022 $141.65M
Eps Diluted FY 2024 · Dec 31, 2022 −$6.41
Eps Basic FY 2024 · Dec 31, 2022 −$6.41
Sga Expense FY 2024 · Dec 31, 2022 $163.96M
Rd Expense FY 2024 · Dec 31, 2022 $373.81M
Net Income FY 2024 · Dec 31, 2022 −$654.59M
Operating Income FY 2024 · Dec 31, 2022 −$544.38M
Stockholders Equity FY 2024 · Dec 31, 2021 $645.01M